Bullous pemphigoid and dipeptidyl peptidase IV inhibitors: a case-noncase study in the French Pharmacovigilance Database

Bullous Pemphigoid Associated With Linagliptin Treatment

(2016) Roger Haber et al.   JAMA Dermatology

Validation and Reproducibility of the Updated French Causality Assessment Method: an Evaluation by Pharmacovigilance Centres & Pharmaceutical Companies

(2015) Hélène Théophile et al.   THERAPIE

Diagnosis and classification of pemphigus and bullous pemphigoid

(2014) Ruben Kershenovich et al.   AUTOIMMUNITY REVIEWS

Bullous pemphigoid induced by vildagliptin: a report of three cases

(2014) Johana Béné et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Drug-induced pemphigoid: a review of the literature

(2014) P.G. Stavropoulos et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Vascular Origin of Vildagliptin-induced Skin Effects in Cynomolgus Monkeys

(2014) Peter Hoffmann et al.   TOXICOLOGIC PATHOLOGY

A Case Report of Bullous Pemphigoid Induced by Dipeptidyl Peptidase-4 Inhibitors

(2013) Iman Aouidad et al.   JAMA Dermatology

Trends of reporting of ‘serious’vs. ‘non-serious’ adverse drug reactions over time: a study in the French PharmacoVigilance Database

(2012) Guillaume Moulis et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Drug reaction with eosinophilia and systemic symptoms (DRESS) in a patient taking sitagliptin

(2012) C. Sin et al.   DIABETES & METABOLISM

Pemphigoid diseases

(2012) Enno Schmidt et al.   LANCET

Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database

(2011) Jean-Louis Montastruc et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Dipeptidyl Peptidase-4 Inhibitors Cause Bullous Pemphigoid in Diabetic Patients: Report of Two Cases

(2011) Efi Pasmatzi et al.   DIABETES CARE

Serotonin Reuptake Inhibitors and Hyperprolactinaemia

(2011) Thierry Trenque et al.   DRUG SAFETY

A review of gliptins in 2011

(2011) André J Scheen   EXPERT OPINION ON PHARMACOTHERAPY

Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin

(2011) K. Skandalis et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Sitagliptin-Associated Drug Allergy: Review of Spontaneous Adverse Event Reports

(2010) Shrey Desai   ARCHIVES OF INTERNAL MEDICINE

Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report

(2010) S. Skalli et al.   DIABETIC MEDICINE

Statins and Erectile Dysfunction

(2009) Catherine Do et al.   DRUG SAFETY

Statin-Associated Psychiatric Adverse Events

(2008) Marco Tuccori et al.   DRUG SAFETY